The UK Calciphylaxis Study

The UK Calciphylaxis Study: a cohort study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN34171966

Enrollment

200

Registered

2012-09-24

Start date

2012-03-01

Completion date

Unknown

Last updated

2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease/ calciphylaxis? Urological and Genital Diseases

Interventions

Baseline clinical information on comorbidity, renal replacement therapy (RRT), medications, standard laboratory variables, skin lesions and diagnosis. Plasma/Serum and clotting sample

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male and female, age more than equal to 18 years 2. Any patient with chronic kidney disease 3. Clinical diagnosis of calciphylaxis 4. Informed consent

Exclusion criteria

Exclusion criteria: Patients who cannot give informed consent

Design outcomes

Primary

Measure	Time frame
Plasma/Serum and clotting samples measured at baseline, week 1 and 2, 1 month	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026